Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2010
08/19/2010WO2010093954A2 Control of plant stress tolerance, water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists
08/19/2010WO2010093814A1 Methods of treating dementia using a gm-csf antagonist
08/19/2010WO2010093802A2 Therapeutic method for increasing pancreatic beta cell mass
08/19/2010WO2010093784A2 Modified virus vectors and methods of making and using the same
08/19/2010WO2010093627A2 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010WO2010093322A1 Methods for identifying therapeutic agents modulating activity of the igf2 repressor zbed6
08/19/2010WO2010093245A1 Antimicrobial peptides based on cmap27
08/19/2010WO2010093055A1 Anti-mst1r antibodies and uses thereof
08/19/2010WO2010092335A1 Method for producing protein
08/19/2010WO2010092219A1 Use of strains of leishmania δhsp70-ii as a vaccine
08/19/2010WO2010092185A2 Scramblase/cd4 interaction inhibitors for the treatment of lentivirus infections
08/19/2010WO2010092182A1 Rbm3 protein in colorectal cancer prognostics
08/19/2010WO2010092135A2 Albumin variants and conjugates
08/19/2010WO2010092112A1 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
08/19/2010WO2010092109A2 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof
08/19/2010WO2010091733A1 Eaat5 activators for the treatment of vestibular deficits
08/19/2010WO2010091692A2 Constitutively active mutants and uses thereof
08/19/2010WO2010075243A3 Nucleotide sequences encoding gsh1 polypeptides and methods of use
08/19/2010WO2010074794A3 Membrane transduction peptides, polynucleotides, and methods
08/19/2010WO2010067308A3 Tmem154 polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
08/19/2010WO2010062383A3 Variants of activin iib receptor polypeptides and uses thereof
08/19/2010WO2010062365A3 A method of protecting against heart failure
08/19/2010WO2010056472A3 Compositions and methods of use for soluble thrombomodulin variants
08/19/2010WO2010048394A3 Vaccine against african horse sickness virus
08/19/2010WO2010048308A3 Natriuretic polypeptides
08/19/2010WO2010025421A3 Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
08/19/2010WO2009156405A9 Novel immunoadjuvant flagellin-based compounds and use thereof
08/19/2010US20100212047 Compositions isolated from forage grasses and methods for their use
08/19/2010US20100212038 Transgenic fish with tissue-specific expression
08/19/2010US20100212037 Mia-2 protein
08/19/2010US20100211325 Laminin binding site
08/19/2010US20100210830 System for inducible expression in eukaryotic cells
08/19/2010US20100210827 Preparation Method Of Recombinant Protein By Use Of A Fusion Expression Partner
08/19/2010US20100210826 Hgf beta chain variants
08/19/2010US20100210822 Modified recombinant human endostatin and uses thereof
08/19/2010US20100210821 Process for isolation and purification of a target protein free of prion protein (prpsc)
08/19/2010US20100210819 Biosensors to measure InsP3 concentration in living cells
08/19/2010US20100210818 Nucleic acids encoding the human alex1 protein
08/19/2010US20100210817 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
08/19/2010US20100210816 NMDAR Biomarkers for Diagnosing and Treating Cerebral Ischemia
08/19/2010US20100210815 Insulin production methods and pro-insulin constructs
08/19/2010US20100210713 Regeneration and survival of cardiac progenitors and cardiomyocytes with a stretch activated transcription factor
08/19/2010US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/19/2010US20100210551 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210550 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210549 Novel Bacillus Thuringiensis Crystal Polypetides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210548 Novel Bacillus Thuringiensis Crystal Polypeptides, Polynucleotides, and Compositions Thereof
08/19/2010US20100210544 Peptides and pharmaceucal compositions for treating connective tissue
08/19/2010US20100210539 Use of peptide ll-37 as a therapeutic agent
08/19/2010US20100210536 Use of leptin (22-56 ) as a therapeutic agent
08/19/2010US20100210529 P53 peptide vaccine
08/19/2010US20100210527 Pro- and anti-angiogenic treatments
08/19/2010US20100210525 Combined preparation of a thiazide diuretic and a loop diuretic
08/19/2010US20100210521 Compositions and methods for modulating ampa receptor-mediated excitotoxicity
08/19/2010US20100210517 Cyclic receptor-associated protein (rap) peptides
08/19/2010US20100210516 Growth Factor Binding Molecules
08/19/2010US20100210515 Methods for preparing purified polypeptide compositions
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210510 Oral lactoferrin in the treatment of sepsis
08/19/2010US20100210508 Method for the Massive Culture of Cells Producing Recombinant Human Erythropoietin
08/19/2010US20100210507 Glycopegylated erythropoietin
08/19/2010US20100210505 Polymer conjugates of glp-1
08/19/2010US20100210035 Human proteins responsible for nedd8 activation and conjugation
08/19/2010US20100210012 Purified mammalian cytokines; related reagents and methods
08/19/2010US20100210004 Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccine
08/19/2010US20100209999 Phage ømru polynucleotides and polypeptides and uses thereof
08/19/2010US20100209998 Cell-permeabilising peptides and polypeptides for microbial cells
08/19/2010US20100209994 Protein Surface Remodeling
08/19/2010US20100209939 Bnp(1-32) epitope and antibodies directed against said epitope
08/19/2010US20100209936 Novel recombinant 15-kDa polypeptide and use of same in detecting human infection with Bartonella henselae
08/19/2010US20100209933 Methods and Compositions for Detection and Enrichment of Target Small RNAs
08/19/2010US20100209923 Probe for diagnosis of marfan syndrome and a method for screening using the probe
08/19/2010US20100209907 Isolated mammalian monocyte cell genes; related reagents
08/19/2010US20100209905 Protein d - an igd-binding protein of haemophilus influenzae
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209453 Circovirus sequence associated with piglet weight loss disease (pwd)
08/19/2010US20100209446 Ostertagia Vaccine
08/19/2010US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
08/19/2010US20100209444 MAGE3 Polypeptides
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209441 Drug for suppressing pathogen occurring in vivo
08/19/2010US20100209436 Method for treating diseases related to mitochondrial dysfunction
08/19/2010US20100209429 Peptides and methods for the treatment of gliomas and other cancers
08/19/2010US20100209414 Methods and Compositions Related to Cyclic Peptide Synthesis
08/19/2010US20100209412 Osteogenesis promoter
08/19/2010US20100209405 Sericin extracted silkworm fibroin fibers
08/19/2010US20100209393 Use of Polynucleotides Encoding Small Acid-Soluble Spore Protein for Inhibiting Bacterial Cell Growth and/or Treating Bacterial Infections
08/19/2010US20100209386 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
08/19/2010US20100209385 Treatment of obesity
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/19/2010US20100209353 Tumor targeting protein conjugate and a method for preparing the same
08/19/2010US20100209346 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
08/19/2010US20100209341 Treatment of chronic inflammatory conditions
08/19/2010DE102004058893B4 Modifizierte Biopolymere, mineralisierte modifizierte Biopolymere, Verfahren zu deren Herstellung und deren Verwendungen Modified biopolymers, modified biopolymers mineralized, to processes for their preparation and their uses
08/19/2010CA2752433A1 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010CA2752033A1 Antibody to cytolethal distending toxin of campylobacter jejuni
08/19/2010CA2751831A1 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof
08/19/2010CA2751758A1 Combinations of polymorphisms for determining allele-specific expression of igf2
1 ... 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 ... 2916